Top Story

FDA approves Iluvien for treatment of DME

September 29, 2014

The U.S. Food and Drug Administration has approved Iluvien for the treatment of diabetic macular edema in patients previously treated with corticosteroids who did not have a significant increase in IOP, Alimera Sciences announced in a press release.

Iluvien (fluocinolone acetonide implant 0.19 mg) was approved with no requirement that patients undergo cataract surgery, according to the release.

Top 5 stories from Vision Expo West

September 26, 2014
Primary Care Optometry News reporters attended Vision Expo West in Las Vegas last week and collected the latest news in ophthalmic technology, treatment strategies and…

Electronic integration is here

September 25, 2014
Growing up in the middle of the last century, I was fascinated by the discovery and invention of new things that changed the world. As a young lad working in my…
Meeting News Coverage

Providers align, quality matters in health care reform

September 23, 2014
LAS VEGAS – “All providers are now on the same side of the table: doctors, hospitals, other ancillary providers. If they do well taking care of patients…
More News Headlines »